$1.53 Billion is the total value of ARMISTICE CAPITAL, LLC's 73 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 62.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VNDA | Sell | VANDA PHARMACEUTICALS INC | $42,367,000 | -3.3% | 2,224,000 | -14.5% | 2.77% | -17.4% |
| SEAS | Sell | SEAWORLD ENTMT INC | $34,388,000 | +15.9% | 1,576,000 | -21.2% | 2.25% | -1.0% |
| ATRS | Sell | ANTARES PHARMA INC | $31,089,000 | +12.5% | 12,050,000 | -4.1% | 2.03% | -3.9% |
| HBI | Sell | HANESBRANDS INC | $28,186,000 | -23.5% | 1,280,000 | -36.0% | 1.84% | -34.6% |
| HAIN | Sell | HAIN CELESTIAL GROUP INCcall | $23,840,000 | -21.1% | 800,000 | -15.1% | 1.56% | -32.6% |
| ENTA | Sell | ENANTA PHARMACEUTICALS INC | $14,372,000 | +34.6% | 124,000 | -6.1% | 0.94% | +14.8% |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $12,948,000 | -56.6% | 2,158,000 | -36.0% | 0.85% | -62.9% |
| ONCE | Sell | SPARK THERAPEUTICS INC | $12,414,000 | +3.6% | 150,000 | -16.7% | 0.81% | -11.6% |
| ACHN | Sell | ACHILLION PHARMACEUTICALS IN | $11,320,000 | -29.0% | 4,000,000 | -6.9% | 0.74% | -39.4% |
| DEPO | Sell | DEPOMED INC | $7,857,000 | -77.8% | 1,177,900 | -78.1% | 0.51% | -81.1% |
| AMZN | Sell | AMAZON COM INC | $3,400,000 | -53.0% | 2,000 | -60.0% | 0.22% | -59.9% |
| NOVN | Sell | NOVAN INC | $1,470,000 | -49.8% | 500,000 | -50.0% | 0.10% | -57.1% |
| BDSI | Sell | BIODELIVERY SCIENCES INTL IN | $357,000 | -80.2% | 120,889 | -84.9% | 0.02% | -83.3% |
| RTTR | Sell | RITTER PHARMACEUTICALS INC | $36,000 | -93.0% | 14,000 | -92.6% | 0.00% | -95.0% |
| APRI | Exit | APRICUS BIOSCIENCES INC | $0 | – | -1,960,000 | -100.0% | -0.06% | – |
| PULM | Exit | PULMATRIX INC | $0 | – | -1,640,000 | -100.0% | -0.06% | – |
| AYTU | Exit | AYTU BIOSCIENCE INC | $0 | – | -1,500,000 | -100.0% | -0.07% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -1,000,000 | -100.0% | -0.10% | – |
| ATNM | Exit | ACTINIUM PHARMACEUTICALS INC | $0 | – | -6,100,000 | -100.0% | -0.17% | – |
| ASMB | Exit | ASSEMBLY BIOSCIENCES INC | $0 | – | -128,000 | -100.0% | -0.48% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -3,592,000 | -100.0% | -0.75% | – |
| AVXS | Exit | AVEXIS INC | $0 | – | -88,000 | -100.0% | -0.83% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -102,000 | -100.0% | -0.91% | – |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -1,836,000 | -100.0% | -1.02% | – |
| SEAS | Exit | SEAWORLD ENTMT INCcall | $0 | – | -1,000,000 | -100.0% | -1.13% | – |
| LC | Exit | LENDINGCLUB CORP | $0 | – | -4,300,000 | -100.0% | -1.15% | – |
| TSCO | Exit | TRACTOR SUPPLY CO | $0 | – | -275,000 | -100.0% | -1.32% | – |
| TLRDQ | Exit | TAILORED BRANDS INC | $0 | – | -800,000 | -100.0% | -1.53% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -1,540,000 | -100.0% | -1.67% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -726,671 | -100.0% | -1.73% | – |
| SAM | Exit | BOSTON BEER INCcl a | $0 | – | -128,000 | -100.0% | -1.85% | – |
| UAA | Exit | UNDER ARMOUR INCcl a | $0 | – | -1,520,000 | -100.0% | -1.90% | – |
| CPB | Exit | CAMPBELL SOUP CO | $0 | – | -628,000 | -100.0% | -2.08% | – |
| POST | Exit | POST HLDGS INC | $0 | – | -392,000 | -100.0% | -2.27% | – |
| CAKE | Exit | CHEESECAKE FACTORY INC | $0 | – | -700,000 | -100.0% | -2.58% | – |
| FRPT | Exit | FRESHPET INC | $0 | – | -2,416,000 | -100.0% | -3.04% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -388,000 | -100.0% | -3.33% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC | 30 | Q3 2023 | 2.7% |
| SPDR S&P 500 ETF TR | 28 | Q3 2023 | 29.5% |
| MADRIGAL PHARMACEUTICALS INC | 27 | Q3 2023 | 2.9% |
| VANDA PHARMACEUTICALS INC | 26 | Q3 2021 | 9.4% |
| REGENERON PHARMACEUTICALS | 25 | Q3 2023 | 3.2% |
| ENERGIZER HLDGS INC NEW | 22 | Q2 2023 | 3.7% |
| ANTARES PHARMA INC | 21 | Q3 2020 | 6.6% |
| INCYTE CORP | 21 | Q3 2023 | 2.8% |
| VOYAGER THERAPEUTICS INC | 21 | Q3 2023 | 2.0% |
| BLUEBIRD BIO INC | 20 | Q4 2021 | 1.8% |
View ARMISTICE CAPITAL, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Avalo Therapeutics, Inc. | June 28, 2023 | 588,850 | 4.7% |
| Addex Therapeutics Ltd. | February 16, 2023 | 675,295 | 5.0% |
| Arcadia Biosciences, Inc. | February 14, 2023 | 2,675,409 | 10.0% |
| Avinger Inc | February 14, 2023 | 789,400 | 10.0% |
| Baudax Bio, Inc. | February 14, 2023 | 1,165,709 | 5.0% |
| BIORA THERAPEUTICS, INC. | February 14, 2023 | 12,989,648 | 5.7% |
| Bit Digital, Inc | February 14, 2023 | 3,161,889 | 3.7% |
| Bruush Oral Care Inc. | February 14, 2023 | 1,122,922 | 10.0% |
| CATALYST PHARMACEUTICALS, INC.Sold out | February 14, 2023 | 0 | 0.0% |
| Clarus Therapeutics Holdings, Inc. | February 14, 2023 | 2,732,169 | 5.0% |
View ARMISTICE CAPITAL, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View ARMISTICE CAPITAL, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.